Digestive System Channel
Topics
Medications
Quicklinks
Related Channels
Thyroid Dysfunction Following Sunitinib
Interested in a Discount on Sunitinib?
Enter your email address to see if eMedTV's free DiscountRx service has a program that could help you save on your prescription(s).
Thank you!
Thank you for your interest in DiscountRx from eMedTV. An email has been sent to the address you provided. Please follow the link within that email to see what offers may be available.
One of the risks associated with the chemotherapy drug sunitinib (SUTENT®) is thyroid dysfunction. Sunitinib can cause an underactive or overactive thyroid during treatment. In most cases, this dysfunction that occurs with sunitinib is reversible following treatment. To help ensure your safety, your healthcare provider will monitor your thyroid function with a blood test before you start the medication and observe you closely for problems while you are taking it.
(For more information, click Warnings and Precautions With Sunitinib. This article gives a more in-depth description of the safety warnings associated with this drug, including information on what to discuss with your healthcare provider and who should avoid it altogether.)
Written by/reviewed by: Susan Lakey, PharmD, MPH, BCPP
Last reviewed by: Kristi Monson, PharmD